Recent genetic studies suggest that ephrins may function in a kinase-independent Eph receptor pathway. Here we report that expression of EphA8 in either NIH 3T3 or HEK293 cells enhanced cell adhesion to fibronectin via ␣ 5  1 -or  3 integrins. Interestingly, a kinase-inactive EphA8 mutant also markedly promoted cell attachment to fibronectin in these cell lines. Using a panel of EphA8 point mutants, we have demonstrated that EphA8 kinase activity does not correlate with its ability to promote cell attachment to fibronectin. Analysis using EphA8 extracellular and intracellular domain mutants has revealed that enhanced cell adhesion is dependent on ephrin A binding to the extracellular domain and the juxtamembrane segment of the cytoplasmic domain of the receptor. EphA8-promoted adhesion was efficiently inhibited by wortmannin, a phosphatidylinositol 3-kinase (PI 3-kinase) inhibitor. Additionally, we found that EphA8 had associated PI 3-kinase activity and that the p110␥ isoform of PI 3-kinase is associated with EphA8. In vitro binding experiments revealed that the EphA8 juxtamembrane segment was sufficient for the formation of a stable complex with p110␥. Similar results were obtained in assay using cells stripped of endogenous ephrin A ligands by treatment with preclustered ephrin A5-Fc proteins. In addition, a membrane-targeted lipid kinase-inactive p110␥ mutant was demonstrated to stably associate with EphA8 and suppress EphA8-promoted cell adhesion to fibronectin. Taken together, these results suggest the presence of a novel mechanism by which the EphA8 receptor localizes p110␥ PI 3-kinase to the plasma membrane in a tyrosine kinase-independent fashion, thereby allowing access to lipid substrates to enable the signals required for integrin-mediated cell adhesion.The Eph receptor tyrosine kinases (RTKs), together with their ephrin ligands, regulate diverse developmental patterning processes including axon guidance, cell migration, and cell segregation (13). However, in contrast to other families of receptor tyrosine kinases, the Eph RTKs do not appear to regulate cell proliferation and survival. It was recently reported that activation of the Eph RTKs by their cognate ligands leads to changes in cell adhesion to various extracellular matrix proteins. For example, EphB1 promoted cell attachment to fibronectin or fibrinogen, whereas neither a kinase-inactive EphB1 mutant nor EphB1 point mutants defective for binding to either Nck or low-molecular-weight protein tyrosine phosphatase (LMW-PTP) showed this effect (21, 35). EphB2 was also shown to indirectly control integrin activity by inducing tyrosine phosphorylation of R-Ras, possibly through a novel signaling intermediate, Src homology 2 (SH2) domain-containing Eph receptor binding protein 1 (SHEP1) (9, 43). More recently, EphA2 kinase was reported to regulate integrin function by causing focal adhesion kinase dephosphorylation (26). These results are consistent with the concept that the kinase activity of the Eph RTKs plays a pivotal role in regulation of ce...